Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 73

Sort by

Sort Order Select

Journal Articles

IAP and HDAC inhibitors interact synergistically in myeloma cells through noncanonical NF-κB– and caspase-8–dependent mechanisms

Blood Adv (2021) 5 (19): 3776–3788.

https://doi.org/10.1182/bloodadvances.2020003597

Published: 2021

Includes: Supplemental data

Journal Articles

Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy

Paraskevi Diamanti, Charlotte V. Cox, Benjamin C. Ede, Robert A. Uger, John P. Moppett, Allison Blair

Blood Adv (2021) 5 (18): 3694–3708.

https://doi.org/10.1182/bloodadvances.2020003534

Published: 2021

Includes: Supplemental data

Journal Articles

Enhanced self-renewal of human long-term hematopoietic stem cells by a sulfamoyl benzoate derivative targeting p18 INK4C

Blood Adv (2021) 5 (17): 3362–3372.

https://doi.org/10.1182/bloodadvances.2020004054

Published: 2021

Includes: Supplemental data

Journal Articles

Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency

Blood Adv (2021) 5 (16): 3174–3187.

https://doi.org/10.1182/bloodadvances.2020003811

Published: 2021

Includes: Supplemental data

Journal Articles

Wild-type HIV infection after treatment with lentiviral gene therapy for β-thalassemia

Suradej Hongeng, Usanarat Anurathapan, Duantida Songdej, Angsana Phuphuakrat, Kesinee Jongrak, Geoffrey Parsons, Briana Deary, Melissa Bonner, Gabor Veres, Mohammed Asmal

Blood Adv (2021) 5 (13): 2701–2706.

https://doi.org/10.1182/bloodadvances.2020003680

Published: 2021

Journal Articles

Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease

Alexis Leonard, Akshay Sharma, Naoya Uchida, David Stroncek, Sandhya R. Panch, Kamille West, Eoghan Molloy, Thomas E. Hughes, Sara Hauffe, Tiffani Taylor, Courtney Fitzhugh, Jane S. Hankins, Megan Wilson, Shengdar Q. Tsai, Mitchell J. Weiss, Matthew Hsieh, John F. Tisdale

Blood Adv (2021) 5 (9): 2403–2411.

https://doi.org/10.1182/bloodadvances.2021004232

Published: 2021

Includes: Supplemental data

Journal Articles

CRISPR-edited megakaryocytes for rapid screening of platelet gene functions

Emilie Montenont, Seema Bhatlekar, Shancy Jacob, Yasuhiro Kosaka, Bhanu K. Manne, Olivia Lee, Ivan Parra-Izquierdo, Emilia Tugolukova, Neal D. Tolley, Matthew T. Rondina, Paul F. Bray, Jesse W. Rowley

Blood Adv (2021) 5 (9): 2362–2374.

https://doi.org/10.1182/bloodadvances.2020004112

Published: 2021

Includes: Supplemental data

Journal Articles

Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR -mutated MPNs

Manjola Balliu, Laura Calabresi, Niccolò Bartalucci, Simone Romagnoli, Laura Maggi, Rossella Manfredini, Matteo Lulli, Paola Guglielmelli, Alessandro Maria Vannucchi

Blood Adv (2021) 5 (8): 2184–2195.

https://doi.org/10.1182/bloodadvances.2020003291

Published: 2021

Includes: Supplemental data

Journal Articles

Using mitochondrial activity to select for potent human hematopoietic stem cells

Jiajing Qiu, Jana Gjini, Tasleem Arif, Kateri Moore, Miao Lin, Saghi Ghaffari

Blood Adv (2021) 5 (6): 1605–1616.

https://doi.org/10.1182/bloodadvances.2020003658

Published: 2021

Includes: Supplemental data

Journal Articles

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

Blood Adv (2021) 5 (5): 1199–1208.

https://doi.org/10.1182/bloodadvances.2020003739

Published: 2021

Includes: Supplemental data

Journal Articles

In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal γ-globin in β-YAC mice

Chang Li, Aphrodite Georgakopoulou, Arpit Mishra, Sucheol Gil, R. David Hawkins, Evangelia Yannaki, André Lieber

Blood Adv (2021) 5 (4): 1122–1135.

https://doi.org/10.1182/bloodadvances.2020003702

Published: 2021

Includes: Supplemental data

Journal Articles

Allogeneic stem cell transplantation with omidubicel in sickle cell disease

Suhag Parikh, Joel A. Brochstein, Einat Galamidi, Aurélie Schwarzbach, Joanne Kurtzberg

Blood Adv (2021) 5 (3): 843–852.

https://doi.org/10.1182/bloodadvances.2020003248

Published: 2021

Includes: Supplemental data

Journal Articles

Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial

Blood Adv (2021) 5 (3): 760–770.

https://doi.org/10.1182/bloodadvances.2020003195

Published: 2021

Includes: Supplemental data

Journal Articles

PML-controlled responses in severe congenital neutropenia with ELANE -misfolding mutations

Patricia A. Olofsen, Dennis A. Bosch, Onno Roovers, Paulina M. H. van Strien, Hans W. J. de Looper, Remco M. Hoogenboezem, Sander Barnhoorn, Pier G. Mastroberardino, Mehrnaz Ghazvini, Vincent H. J. van der Velden, Eric M. J. Bindels, Emma M. de Pater, Ivo P. Touw

Blood Adv (2021) 5 (3): 775–786.

https://doi.org/10.1182/bloodadvances.2020003214

Published: 2021

Includes: Supplemental data

Journal Articles

Variable CD34 + recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic

Duncan Purtill, Vicki Antonenas, Paul Chiappini, Daochen Tong, Elizabeth O’Flaherty, Ashish Bajel, Karieshma Kabani, Stephen Larsen, Suikeat Tan, Cheryl Hutchins, David J. Curtis, Glen A. Kennedy, Anne-Marie Watson, LiJun Bai, Matthew Greenwood, David J. Gottlieb, Nada Hamad

Blood Adv (2020) 4 (17): 4147–4150.

https://doi.org/10.1182/bloodadvances.2020002431

Published: 2020

Includes: Supplemental data

Journal Articles

Diagnostic assay to assist clinical decisions for unclassified severe combined immune deficiency

Panojot Bifsha, Jennifer W. Leiding, Sung-Yun Pai, Aurelien B. L. Colamartino, Nicholas Hartog, Joseph A. Church, Benjamin R. Oshrine, Jennifer M. Puck, M. Louise Markert, Elie Haddad

Blood Adv (2020) 4 (12): 2606–2610.

https://doi.org/10.1182/bloodadvances.2020001736

Published: 2020

Includes: Supplemental data

Journal Articles

Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia

Blood Adv (2020) 4 (12): 2611–2616.

https://doi.org/10.1182/bloodadvances.2020001730

Published: 2020

Includes: Supplemental data

Journal Articles

Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden

Theodoros Karantanos, Shruti Chaturvedi, Evan M. Braunstein, Jerry Spivak, Linda Resar, Styliani Karanika, Donna M. Williams, Ophelia Rogers, Christopher D. Gocke, Alison R. Moliterno

Blood Adv (2020) 4 (12): 2567–2576.

https://doi.org/10.1182/bloodadvances.2019001407

Published: 2020

Includes: Supplemental data

Journal Articles

Targeting CD300f to enhance hematopoietic stem cell transplantation in acute myeloid leukemia

Edward Abadir, Pablo A. Silveira, Robin E. Gasiorowski, Murari Ramesh, Adelina Romano, Ahmed H. Mekkawy, Tsun-Ho Lo, Karieshma Kabani, Sarah Sutherland, Geoffrey A. Pietersz, P. Joy Ho, Christian E. Bryant, Stephen R. Larsen, Georgina J. Clark

Blood Adv (2020) 4 (7): 1206–1216.

https://doi.org/10.1182/bloodadvances.2019001289

Published: 2020

Includes: Supplemental data

Journal Articles

Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post–autologous stem cell transplantation

Johannes Frasez Soerensen, Anni Aggerholm, Gitte Birk Kerndrup, Marcus Celik Hansen, Ina Kathrine Lykke Ewald, Marie Bill, Lene Hyldahl Ebbesen, Carina Agerbo Rosenberg, Peter Hokland, Maja Ludvigsen, Anne Stidsholt Roug

Blood Adv (2020) 4 (5): 885–892.

https://doi.org/10.1182/bloodadvances.2019001157

Published: 2020

Includes: Supplemental data

NARROW

IAP and HDAC inhibitors interact synergistically in myeloma cells through noncanonical NF-κB– and caspase-8–dependent mechanisms

Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy

Enhanced self-renewal of human long-term hematopoietic stem cells by a sulfamoyl benzoate derivative targeting p18 INK4C

Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency

Wild-type HIV infection after treatment with lentiviral gene therapy for β-thalassemia

Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease

CRISPR-edited megakaryocytes for rapid screening of platelet gene functions

Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR -mutated MPNs

Using mitochondrial activity to select for potent human hematopoietic stem cells

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal γ-globin in β-YAC mice

Allogeneic stem cell transplantation with omidubicel in sickle cell disease

Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial

PML-controlled responses in severe congenital neutropenia with ELANE -misfolding mutations

Variable CD34 + recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic

Diagnostic assay to assist clinical decisions for unclassified severe combined immune deficiency

Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia

Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden

Targeting CD300f to enhance hematopoietic stem cell transplantation in acute myeloid leukemia

Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post–autologous stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only